Special Populations Clinical Pharmacology Unit (CPU)
This clinical pharmacology offers a layout which is suited towards conducting early phase studies in special patient populations.
Costa Mesa, CA
The Costa Mesa 25,000 sq. ft. clinical pharmacology Unit (CPU) has a strong focus on special population studies. With 30 rooms able to house up to 60 subjects, Costa Mesa offers many distinct characteristics to ensure your study’s success.
- Certified on-site PBMC processing – by the CPT Method or the Ficoll-Paque method – is capable of producing up to 200 samples per day
- Lab equipped with multiple type II Biological Safety Cabinets
- Extensive experience in pediatric pharmacokinetic (PK) studies requiring subjects to stay in-house with their caregivers
- Pediatric-friendly facility
- 24/7 accommodations for specific client programs and protocols
- Crash carts in all units with medications/equipment to support a full code
- On-site pharmacy with its own clean room
- Dedicated recruitment call center focused on patient population studies
- Experienced staff capable of handling the complexities of working with these patient types and their families.
Other Notable Features/Capabilities
- Postmenopausal women
- Rheumatoid arthritis
- Influenza challenge studies
- Large, open phlebotomy areas
- ECG rooms with multiple stations
- Semiprivate subject rooms
- Various subject entertainment options
- Two spacious PK sample lab processing areas
- Large monitoring stations with phones and high-speed internet access
- Securely locked ambient and refrigerated drug storage room
- Two pharmacy dosing and storage areas with a USP 797 compliant cleanroom with ISO 5 Laminar Flow Hood (LFH)
- Secure medical records and CRF storage rooms
Dr. Bonnie Bock
In addition to serving as WCCT’s Primary Investigator for infectious disease programs, Dr. Bock is a private practice physician in Newport Beach, CA, focusing on infectious diseases. Additionally, she served for many years as Medical Director of the Baromedical Unit at the Hoag Memorial Hospital, is a former president of the Infectious Diseases Association of California and remains an active member of the board.
She is board-certified in Internal Medicine and has a degree in medical technology for the American Society of Clinical Pathologists. Dr. Bock specializes in HIV and received her HIV Specialist Certification from 2003 to 2014 from the American Academy of HIV Medicine.
Having over 40 years of experience, Dr. Bock has established herself as an expert in the field. She was named Woman of the Year in Medicine & Healthcare in 2009, and one of the Best Doctors in America in 2010. She has spoken at multiple conferences, on a local and national level and on topics relating to infectious diseases.
Joining WCCT in January 2015, Dr. Bock served as the Principal Investigator and Subinvestigator for over 25 early and late-stage trials in multiple therapeutic indications at the company’s Phase I-IV units. Most recently, Dr. Bock was instrumental as the PI for WCCT’s titration study, which used the Viral Challenge Model at their Influenza Challenge Facility in early 2015.
This study enrolled 35 subject volunteers, all of whom had not received an influenza vaccine within the previous two years; the study determined that up to 30% of the general population lacks immunity to H1N1, making them at risk for an H1N1 pandemic. She is currently serving as the PI for a BARDA-funded human challenge study in influenza, solidifying her as one of WCCT’s most experienced experts in the innovative field of influenza challenge research.
Early Clinical Development
Stay up-to-date on clinical research news and developments.
Careers that put you at the forefront of medical breakthroughs.
The blog delivers industry-related developments and announcements regarding expanded clinical services.